Enright Patrick G
- SEC CIK
- 0001253886
In the past year, 3 open-market purchase filings worth $20.8M and 2 sale filings worth $663.9K.
Current role at each company
- JAZZ Jazz Pharmaceuticals plcDirectoras of Sep 2, 2026
- ZBIO Zenas BioPharma, Inc.Directoras of Jun 17, 2026
- BIOA BioAge Labs, Inc.Directoras of Jun 12, 2026
- VERA Vera Therapeutics, Inc.Directoras of May 26, 2026
- RPID Rapid Micro Biosystems, Inc.10% Owneras of Feb 6, 2026
Show 5 more companies
- MANE Veradermics, IncDirector, 10% Owneras of Feb 5, 2026
- LXEO Lexeo Therapeutics, Inc.10% Owneras of Nov 9, 2023
- APTX Aptinyx Inc.Directoras of May 31, 2022
- SRRA Sierra Oncology, Inc.10% Owneras of Apr 29, 2022
- INZY Inozyme Pharma, Inc.10% Owneras of Apr 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $20.8M
- 3 filings
- Sold
- $663.9K
- 2 filings
- Net
- +$20.1M
- Bought minus sold
- Companies
- 4
- With open-market trades
Trades
Every Form 4 that lists Enright Patrick G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RPID Rapid Micro Biosystems, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing)4:26 PM ET | Feb 4 | 2 days | Enright Patrick G and 5 others10% Owner | SSaleClass A Common Stock | −49.0K | $3.88 | −$190.1K | −100.0%0 after | |
| Feb 3, 2026 (view filing)8:50 PM ET | Jan 23-Feb 3 | 11 daysLate | Enright Patrick G and 4 others10% Owner | SSaleClass A Common Stock | −108.7K | $4.36 | −$473.9K | −68.9%49.0K after | 4 lots |
| Jul 20, 2021 (view filing)9:39 PM ET | Jul 19 | 1 day | Enright Patrick G and 5 others10% Owner | PPurchaseClass A Common Stock | +150.0K | $20.00 | +$3.00M | New position150.0K after |
MANE Veradermics, Inc
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 (view filing) | Feb 5 | Same day | Enright Patrick GDirector, 10% Owner | PPurchase | +1.07M | $17.00 | +$18.3M | +109.9%2.05M after | 2 lots |
VERA Vera Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Enright Patrick GDirector | PPurchaseClass A Common Stock | +5.88K | $42.50 | +$250.0K | New position5.88K after | |
| Jun 25, 2025 (view filing) | Jun 23-24 | 2 days | Enright Patrick GDirector | PPurchaseClass A Common Stock | +250.0K | $21.11 | +$5.28M | +7.5%3.60M after | 4 lots |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Enright Patrick GDirector, 10% Owner | PPurchaseClass A Common Stock | +1.71M | $7.00 | +$12.0M | New position1.71M after | |
| Apr 5, 2022 (view filing) | Feb 10 | 54 daysLate | Enright Patrick GDirector, 10% Owner | PPurchaseClass A Common Stock | +333.3K | $15.00 | +$5.00M | +10.8%3.43M after |
ZBIO Zenas BioPharma, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 (view filing) | Oct 9 | 5 days | Enright Patrick GDirector | PPurchase | +105.3K | $19.00 | +$2.00M | +6.1%1.83M after | |
| Oct 14, 2025 (view filing) | Oct 9 | 5 days | Enright Patrick GDirector | PPurchase | +12.0K | $20.85 | +$250.0K | New position12.0K after | |
| Sep 16, 2024 (view filing) | Sep 16 | Same day | Enright Patrick GDirector | PPurchase | +440.0K | $17.00 | +$7.48M | +131.5%774.5K after |
BIOA BioAge Labs, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 (view filing) | Sep 27 | Same day | Enright Patrick GDirector | PPurchase | +400.0K | $18.00 | +$7.20M | +30.5%1.71M after |
LXEO Lexeo Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2023 (view filing)8:32 PM ET | Nov 7 | 2 days | Enright Patrick G and 3 others10% Owner | PPurchase | +454.5K | $11.00 | +$5.00M | +21.5%2.57M after |
JAZZ Jazz Pharmaceuticals plc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 (view filing) | Aug 14 | 1 day | Enright Patrick GDirector | SSale | −1.24K | $138.16 | −$171.5K | −5.6%20.9K after | |
| Nov 25, 2022 (view filing) | Nov 22 | 3 days | Enright Patrick GDirector | SSale | −4.97K | $149.48 | −$743.5K | −20.7%19.1K after | 2 lots |
| Nov 25, 2022 (view filing) | Nov 22 | 3 days | Enright Patrick GDirector | SSale | −2.00K | $152.88 | −$305.8K | −100.0%0 after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Enright Patrick GDirector | SSale | −1.09K | $152.33 | −$165.9K | −4.3%24.1K after |
INZY Inozyme Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 (view filing)6:04 PM ET | Apr 19 | 2 days | Enright Patrick G and 3 others10% Owner | PPurchase | +1.35M | $3.69 | +$5.00M | +48.1%4.17M after |
SRRA Sierra Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 (view filing)9:25 PM ET | Feb 2 | Same day | Enright Patrick G and 5 others10% Owner | PPurchase | +175.0K | $27.00 | +$4.72M | New position175.0K after | Duplicate filing |